| Background: Tumor length in patients with esophageal cancer (EC) has recently received great attention.
However, its prognostic role for EC is controversial. The purpose of our study was to characterize the prognostic
value of tumor length in EC patients and offer the optimum cut-off point of tumor length by reliable statistical
methods. Materials and Methods: A retrospective analysis was conducted on 71 consecutive patients with EC
who underwent surgery. ROC curve analysis was used to determine the optimal cut-off point for tumor length,
measured with a handheld ruler after formalin fxation. Correlations between tumor length and other factors
were surveyed, and overall survival (OS) rates were compared between the two groups. Potential prognostic
factors were evaluated by univariate Kaplan-Meier survival analysis. A P value less than 0.05 was considered
signifcant. Results: There were a total of 71 patients, with a male/ female divide of 43/28 and a median age of
59. Characteristics were as follows: squamous/adenocarcinoma, 65/6; median tumor length, 4 (0.9–10); cut-off
point for tumor length, 4cm. Univariate analysis prognostic factors were tumor length and modality of therapy.
One, three and fve year OS rates were 84, 43 and 43% for tumors with ≤4cm length, whereas the rates were
75, 9 and 0% for tumors >4 cm. There was a signifcant association between tumor length and age, sex, weight
loss, tumor site, histology, T and N scores, differentiation, stage, modality of therapy and longitudinal margin
involvement. Conclusions: Future studies for modifcation of the EC staging system might consider tumor length
too as it is an important prognostic factor. Further assessment with larger prospective datasets and practical
methods (such as endoscopy) is needed to establish an optimal cut-off point for tumor length. |